Business
Why the CSL (ASX:CSL) share price has rebounded 13% since March
The CSL Limited (ASX: CSL) share price has been rebounding lately after hitting a 52-week low of $242.00 on 9 March. Since then, the company has gained 12.95%, with CSL shares currently trading at $273.35.
The global biotech has been busy producing the AstraZeneca COVID-19 vaccine while attempting to combat plasma collection concerns. Could this be the catalyst for its recent share price rise?
What’s driving the CSL share price higher?
Investors appear upbeat about the company’s progress to address its current issues as well as its attempts to open up new opportunities.
As announced on 14 April, CSL has been focused on increasing its plasma-protein production through its launch of a global challenge. The company is inviting…
-
Noosa News22 hours agoBali traveller sparks urgent measles alert across Queensland
-
Noosa News21 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business24 hours agoEverything you need to know about the Coles dividend
-
Business22 hours agoThe best ASX ETFs for compounding wealth until 2040